We are live on ! Find out more
Pictet Asset Management

Pictet Asset Management Portfolio holdings

AUM $105B
1-Year Est. Return 38.07%
This Fund
S&P 500
This Quarter Est. Return
+2.76%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
10 Year Est. Return
AUM
$87.3B
AUM Growth
-$4.6B
Cap. Flow
-$5.51B
Cap. Flow %
-6.32%
Top 10 Hldgs %
18.42%
Holding
2,054
New
81
Increased
677
Reduced
810
Closed
85

Sector Composition

Rank Sector Weight
1 Technology 33.21%
2 Industrials 17.72%
3 Healthcare 13.34%
4 Consumer Discretionary 7.59%
5 Utilities 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSCI icon
476
MSCI
MSCI
$40.8B
$19.3M 0.02%
40,102
-10,796
-21% -$5.36M
IQV icon
477
IQVIA
IQV
$40.1B
$19.2M 0.02%
90,936
+12,374
+16% +$2.81M
GH icon
478
Guardant Health
GH
$22.2B
$19.2M 0.02%
664,108
-485,513
-42% -$11.3M
TTC icon
479
Toro Company
TTC
$9.41B
$19M 0.02%
202,825
-1,732,578
-90% -$153M
GEV icon
480
GE Vernova
GEV
$269B
$18.9M 0.02%
+110,046
New +$17.4M
IT icon
481
Gartner
IT
$11.8B
$18.8M 0.02%
41,789
+419
+1% +$186K
ODFL icon
482
Old Dominion Freight Line
ODFL
$43.4B
$18.7M 0.02%
105,652
-181
-0.2% -$34.1K
PLTR icon
483
Palantir
PLTR
$420B
$18.6M 0.02%
733,041
+26,188
+4% +$590K
UTHR icon
484
United Therapeutics
UTHR
$22.1B
$18.3M 0.02%
57,512
-63,567
-53% -$16.8M
DOC icon
485
Healthpeak Properties
DOC
$14.1B
$18.3M 0.02%
934,185
+100,350
+12% +$1.92M
EMB icon
486
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$18.3M 0.02%
+206,749
New +$18.3M
CTVA icon
487
Corteva
CTVA
$50.9B
$18.2M 0.02%
337,713
-6,174
-2% -$340K
AGIO icon
488
Agios Pharmaceuticals
AGIO
$1.95B
$18.2M 0.02%
422,044
-583,582
-58% -$21.1M
ELVN icon
489
Enliven Therapeutics
ELVN
$4.31B
$18.2M 0.02%
+778,109
New +$16.4M
ED icon
490
Consolidated Edison
ED
$39.8B
$18.1M 0.02%
201,912
-15,697
-7% -$1.46M
RS icon
491
Reliance Steel & Aluminium
RS
$21.6B
$18M 0.02%
63,024
-6,387
-9% -$1.92M
AME icon
492
Ametek
AME
$58.8B
$17.9M 0.02%
107,666
-43,397
-29% -$7.5M
LRN icon
493
Stride
LRN
$3.29B
$17.9M 0.02%
254,585
-115,652
-31% -$7.71M
VICI icon
494
VICI Properties
VICI
$28.6B
$17.9M 0.02%
625,298
+28,361
+5% +$814K
BBY icon
495
Best Buy
BBY
$17.6B
$17.8M 0.02%
211,303
+4,569
+2% +$363K
IXN icon
496
iShares Global Tech ETF
IXN
$9.2B
$17.8M 0.02%
214,700
-125,700
-37% -$9.58M
NDAQ icon
497
Nasdaq
NDAQ
$53.1B
$17.6M 0.02%
292,861
-17,222
-6% -$1.04M
SLNO
498
DELISTED
Soleno Therapeutics
SLNO
$17.6M 0.02%
431,760
+97,908
+29% +$4.15M
VMC icon
499
Vulcan Materials
VMC
$37.3B
$17.6M 0.02%
70,720
+12,316
+21% +$3.18M
CM icon
500
Canadian Imperial Bank of Commerce
CM
$109B
$17.5M 0.02%
363,390
-955
-0.3% -$46.3K

Similar funds

Pictet Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Pictet Asset Management held 2,054 positions worth $87.3B, down 5% from $91.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Pictet Asset Management withdrew a net $5.51B in Q2 2024, closing 85 positions and reducing 810 holdings. Its most notable exit was Immunocore, an estimated $45.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Pictet Asset Management opened a new position in iShares TIPS Bond ETF worth $35.1M.

  • Pictet Asset Management's largest Q2 2024 buy was iShares TIPS Bond ETF: 327,700 shares worth $35.1M.
  • Pictet Asset Management added most to Alphabet (Google) Class A in Q2 2024, an estimated $571M increase.
  • Pictet Asset Management's biggest Q2 2024 reduction was Alphabet (Google) Class C, cutting an estimated $881M.
  • Pictet Asset Management fully exited Immunocore in Q2 2024, selling an estimated $45.9M.
  • Pictet Asset Management's ten largest holdings make up 18% of its $87.3B portfolio in Q2 2024.
  • Pictet Asset Management opened 81 new positions and closed 85 in Q2 2024.
  • Pictet Asset Management's portfolio value fell 5% quarter-over-quarter to $87.3B.

Based on Pictet Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.